700 heart infection patients enrolled in landmark study to improve care
NCT ID NCT04992923
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 700 patients with infective endocarditis, a serious heart infection, to gather real-world data on complications and outcomes. Researchers aim to improve treatment guidelines, which currently rely on expert opinion due to limited evidence. No new drug or treatment is being tested.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could provide better guidelines for managing infective endocarditis and reducing its complications.
- What could go wrong
- This is an observational study, not a treatment trial. It cannot directly improve outcomes, and results may take years to influence practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFECTIVE ENDOCARDITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
APHP Pitié-Salpêtrière Hospital, Department of Cardiology
RECRUITINGParis, 75013, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple dental cleaning prevent a deadly heart infection?
- Heart infection registry aims to unlock better treatments
- New diagnostic tool could speed up treatment for deadly heart infection
- New antibiotic strategy could shorten hospital stays for heart infections
- Massive infection database aims to unlock secrets of deadly diseases
- New imaging study aims to reduce misdiagnosis of heart valve infections